Literature DB >> 11561022

Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease.

N Andreasen, J Gottfries, E Vanmechelen, H Vanderstichele, P Davidson, K Blennow, L Rosengren, K Blennow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11561022      PMCID： PMC1763527          DOI： 10.1136/jnnp.71.4.557

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

Review 1.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

2.  MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Authors:  P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

3.  MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.

Authors:  P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

4.  Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases.

Authors:  Magdalena Nutu; Philippe Bourgeois; Henrik Zetterberg; Erik Portelius; Ulf Andreasson; Stéphane Parent; Francesco Lipari; Sara Hall; Radu Constantinescu; Oskar Hansson; Kaj Blennow
Journal:  Neuromolecular Med       Date:  2012-12-07       Impact factor: 3.843

5.  Imaging and biomarkers in early Alzheimer's disease and mild cognitive impairment.

Authors:  R C Petersen; C R Jack
Journal:  Clin Pharmacol Ther       Date:  2009-08-26       Impact factor: 6.875

6.  HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer's Disease Brain.

Authors:  María-Salud García-Ayllón; Arancha Botella-López; Inmaculada Cuchillo-Ibañez; Alberto Rábano; Niels Andreasen; Kaj Blennow; Jesús Ávila; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2016-01-06       Impact factor: 5.590

7.  Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months.

Authors:  Catherine Chiu; Miles C Miller; Ilias N Caralopoulos; Michael S Worden; Thomas Brinker; Zachary N Gordon; Conrad E Johanson; Gerald D Silverberg
Journal:  Fluids Barriers CNS       Date:  2012-01-23

8.  CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.

Authors:  Barbara B Bendlin; Cynthia M Carlsson; Sterling C Johnson; Henrik Zetterberg; Kaj Blennow; Auriel A Willette; Ozioma C Okonkwo; Aparna Sodhi; Michele L Ries; Alex C Birdsill; Andrew L Alexander; Howard A Rowley; Luigi Puglielli; Sanjay Asthana; Mark A Sager
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

Review 9.  Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Craig Ritchie; Nadja Smailagic; Anna H Noel-Storr; Yemisi Takwoingi; Leon Flicker; Sam E Mason; Rupert McShane
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.